- Home
- KLTO vs ALBT Comparison
KLTO vs ALBT Comparison
Compare KLTO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- ALBT
- Stock Information
- Founded
- KLTO 2019
- ALBT 2014
- Country
- KLTO United States
- ALBT United States
- Employees
- KLTO N/A
- ALBT N/A
- Industry
- KLTO
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KLTO
- ALBT Health Care
- Exchange
- KLTO NYSE
- ALBT Nasdaq
- Market Cap
- KLTO 9.8M
- ALBT 7.9M
- IPO Year
- KLTO N/A
- ALBT N/A
- Fundamental
- Price
- KLTO $0.18
- ALBT $4.80
- Analyst Decision
- KLTO
- ALBT
- Analyst Count
- KLTO 0
- ALBT 0
- Target Price
- KLTO N/A
- ALBT N/A
- AVG Volume (30 Days)
- KLTO 78.7K
- ALBT 83.2K
- Earning Date
- KLTO 05-15-2025
- ALBT 05-30-2025
- Dividend Yield
- KLTO N/A
- ALBT N/A
- EPS Growth
- KLTO N/A
- ALBT N/A
- EPS
- KLTO N/A
- ALBT N/A
- Revenue
- KLTO N/A
- ALBT $486,815.00
- Revenue This Year
- KLTO N/A
- ALBT N/A
- Revenue Next Year
- KLTO N/A
- ALBT N/A
- P/E Ratio
- KLTO N/A
- ALBT N/A
- Revenue Growth
- KLTO N/A
- ALBT N/A
- 52 Week Low
- KLTO $0.20
- ALBT $2.11
- 52 Week High
- KLTO $13.10
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- ALBT 44.79
- Support Level
- KLTO N/A
- ALBT $5.18
- Resistance Level
- KLTO N/A
- ALBT $7.89
- Average True Range (ATR)
- KLTO 0.00
- ALBT 0.54
- MACD
- KLTO 0.00
- ALBT -0.17
- Stochastic Oscillator
- KLTO 0.00
- ALBT 5.03
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.